ロード中...
The DREAM complex in anti-tumor activity of imatinib mesylate in gastrointestinal stromal tumors (GISTs)
PURPOSE OF REVIEW: Although most gastrointestinal stromal tumors (GISTs) respond well to treatment with the small molecule kinase inhibitor imatinib mesylate (Gleevec), the majority of patients achieve disease stabilization and complete remissions are rare. Furthermore, discontinuation of treatment...
保存先:
| 出版年: | Curr Opin Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4236229/ https://ncbi.nlm.nih.gov/pubmed/24840522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000090 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|